Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M Echave
Observed names:
M ECHAVE,
M. Echave,
Maria Echave,
María Echave
Institution:
Pharmacoeconomics and Health Outcomes Research Iberia (Spain)
Observed institutions:
University of Padua,
Innsbruck Medical University,
Jahra Hospital,
Corporació Sanitària Parc Taulí,
Pfizer (Spain),
Takeda (United States),
Iberia (Spain),
SHOWA Medical University Fujigaoka Hospital,
Pharmacoeconomics and Health Outcomes Research Iberia (Spain)
show all 9
ORCID:
0000-0001-6814-2177
Observed ORCID:
0000-0001-6814-2177
OpenAlex ID:
A5008733871
Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review
2014
·
María Echave
, Itziar Oyagüez
, et al.
·
BMC Surgery
·
122
PDF
Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain
2015
·
Jose Miguel Rodríguez González-Moro
, Rosario Menéndez
, et al.
·
Clinical Drug Investigation
·
32
PDF
Cost‐utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemia
2017
·
Luis Felipe Casado
, José Ángel Hernández
, et al.
·
European Journal Of Haematology
·
16
PDF
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis
2015
·
Blanca Gros
, Antonio Galán
, et al.
·
Health Economics Review
·
8
PDF
Aflibercept in Combination with Folfiri in Patients with Metastatic Colorectal Cancer: Cost-Effectiveness Based on Velour Best Efficacy Subgroup Post-Hoc Analysis
2015
·
M Echave
, I Oyagüez
, et al.
·
Value in Health
·
5
[Cost-effectiveness analysis of aflibercept in combination with FOLFIRI in the treatment of patients with metastatic colorectal cancer].
2014
·
C Pericay
, C Frías
, et al.
·
PubMed
·
5
Are Trends in Economic Modeling of Pediatric Diabetes Mellitus up to Date with the Clinical Practice Guidelines and the Latest Scientific Findings?
2025
·
Roque Cardona-Hernandez
, Alberto de la Cuadra-Grande
, et al.
·
Journal of health economics and outcomes research
·
4
Cost-Analysis for Toxicity Management in Advanced Squamous Non-Small Cell Lung Cancer: Nivolumab vs Docetaxel
2016
·
N Ortega-Joaquin
, M Echave
, et al.
·
Value in Health
·
4
Cost-Effectiveness Of Tiotropium In The Treatment Of Patients With Asthma
2015
·
M Echave
, ME Ojanguren
, et al.
·
Value in Health
·
4
PDF
Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Psoriasis In Spain
2015
·
JM Carrascosa
, F Vanaclocha
, et al.
·
Value in Health
·
3
Pcn108 Nivolumab-adjuvant Therapy for Resected Stage Iii-iv Melanoma: a Cost-effectiveness Analysis for Spain
2019
·
M. Presa
, A. Soria
, et al.
·
Value in Health
·
2
PDF
Eficiencia de un tratamiento de duración fija con Venetoclax en combinación con Rituximab en pacientes con Leucemia Linfocítica Crónica (LLC)
2021
·
Raúl Ferrando Piqueres
, Eduardo Ríos
, et al.
·
Actualidad en farmacología y terapéutica
·
1
PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain
2020
·
R. Ferrando
, M. Echave
, et al.
·
Value in Health
·
1
Cost-Utility of Idelalisib In Combination with Rituximab In Relapsed or Refractory Chronic Lymphocytic Leukemia
2017
·
LF Casado
, JA Hernandez
, et al.
·
Value in Health
·
1
Efficiency of nivolumab in the treatment of second-line advanced non-squamous non-small cell lung cancer (NSCLC) in Spain
2017
·
P. González
, N. Ortega-Joaquín
, et al.
·
Annals of Oncology
·
1
Cost-Utility Analysis of Nivolumab Monotherapy for Metastatic Melanoma Treatment
2016
·
M Echave
, Oyagüez
, et al.
·
Value in Health
·
1
Words (Excluding Tãtle and Authors: 300) Title: Cost-Effectiveness Analysis of Nivolumab for the Treatment of Second-Line Advanced Squamous Non-Small Cell Lung Cancer (Nsclc) in Spain
2016
·
P González García
, E Felip
, et al.
·
Value in Health
·
1
Cost-Utility Analysis of Apremilast for The Treatment of Psoriatic Arthritis Patients In Spain
2015
·
CM Gonzalez
, R Almodóvar
, et al.
·
Value in Health
·
1
Dialysis Bone Disease
2014
·
M. Fusaro
, S. Giannini
, et al.
·
Nephrology Dialysis Transplantation
·
1
Cost-Effectiveness of a 13-Valent Conjugate Pneumococcal Vaccination Program in COPD Patients Aged ≥50 Years in Spain: Preliminary Results
2013
·
R. Menendez
, J.M. Rodríguez-GonzálezMoro
, et al.
·
Value in Health
·
1
PIN24 Clinical and Economic Evaluation of an Adult Pneumococcal Vaccination Programme Aimed at the Spanish HIV Population
2012
·
P. Guijarro
, M. Echave
·
Value in Health
·
1
[Determination of urinary 17-ketosteroids; normal values and excretion in different pathological states].
1953
·
M E ANGERS
, M ECHAVE
, et al.
·
PubMed
·
1
EE687 Cost Analysis of Prostav®: A New Telomere-Based Biomarker for the Early Detection of Prostate Cancer Available in Europe
2023
·
M. Parramon
, M. Juárez
, et al.
·
Value in Health
PDF
Productividad laboral y doméstica con certolizumabpegol en pacientes con espondiloartritis axial noradiográfica en España: un análisis de costes
2021
·
R Ferrando
, MA Belmonte-Serrano
, et al.
·
Economía de la Salud
PDF
Prm62 - a Systematic Review of Economic Evaluations Based on Decision-analytic Modeling of Cancer Drugs
2018
·
S Rico
, M Echave
, et al.
·
Value in Health
Show more works
View as search
Works count:
29
Citation count:
216
H-index:
5
I10-index:
3
Year
Topic
Type